In conclusion, the role of TARBP2 through mediation of miR-145 and a downstream player SERPINE1 was established in HCC progression, thus providing a new intervention pathway (e.g. HIF-1 pathway) that could be exploited to improve the clinical outcomes of HCC in the future (Figure 8). This evidence concerns the gene TARBP2 and hepatocellular carcinoma.